![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Marinus Pharma Receives FDA Orphan Drug Designation for Ganaxolone to Treat Fragile X Syndrome
Marinus Pharmaceuticals Inc , a biopharmaceutical company dedicated to the development of innovative therapeutics to...
Clinical research data sharing promises new cures and treatments
Clinical research generates extensive amounts of data, yet most of it is siloed or generally...
Glenmark Pharma gets USFDA approval for Tretinoin Capsules
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food...
IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery
IBM Watson Health and Pfizer Inc announced a collaboration that will utilize IBM Watson for...
Global market will reach $26 billion by 2020, says GBI Research
The global market for drug delivery technologies will rise from $20 billion in 2015 to...
Neos Therapeutics Submits NDA for Amphetamine Extended-Release Liquid Suspension Drug Candidate, Amphetamine, for the...
Neos Therapeutics a pharmaceutical company focused on developing and commercializing innovative extended-release (XR) products for...
Ra Pharmaceuticals Receives Orphan Drug Designation in the European Union for RA101495 for Treatment...
Ra Pharmaceuticals , a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics...
BioSpecifics Technologies Corp. Announces Positive Data from Phase 2b Study of CCH in Patients...
BioSpecifics Technologies Corp , a biopharmaceutical company that originated and continues to develop collagenase based-therapies...
Bristol-Myers Squibb and Enterome Announce Immuno-Oncology Collaboration Focused on Microbiome-Derived Biomarkers, Drug Targets and...
Bristol-Myers Squibb Company and Enterome, a pioneer in the development of pharmaceuticals and diagnostics based...
Cytori Granted FDA Orphan Drug Designation for ECCS-50 in Scleroderma
Cytori Therapeutics, Inc. announced that the US FDA Office of Orphan Products Development (OOPD) has...